XLO - Xilio Therapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$98.00
DETAILS
HIGH:
$98.00
LOW:
$98.00
MEDIAN:
$98.00
CONSENSUS:
$98.00
UPSIDE:
1087.88%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Revenue | |||||||
| Revenue | 43.8 | 6.3 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | 1.5 | 0 | 0 | 0 | 1.5 | 1.1 | 0.2 |
| Gross Profit | 42.2 | 6.3 | 0 | 0 | (1.5) | (1.1) | (0.2) |
| Operating Expenses | |||||||
| R&D Expenses | 56.0 | 41.2 | 52.1 | 59.2 | 51.2 | 43.9 | 14.3 |
| SG&A Expenses | 29.7 | 24.8 | 27.0 | 29.9 | 22.4 | 9.6 | 4.5 |
| Other Expenses | (1.5) | 0.9 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses | 84.2 | 66.9 | 79.1 | 89.1 | 73.5 | 53.5 | 18.8 |
| Operating Income | |||||||
| Operating Income | (42.0) | (60.6) | (79.1) | (89.1) | (75.0) | (54.6) | (19.0) |
| Interest Expense | 0 | 0.1 | 0 | 0 | 0.6 | 0.6 | 0 |
| Interest Income | 3.4 | 0 | 0 | 0 | 0.0 | 0.0 | 0 |
| Profitability | |||||||
| EBITDA | (40.4) | (58.0) | (77.2) | (87.3) | (73.7) | (53.6) | (17.1) |
| EBIT | (42.0) | (59.6) | (79.1) | (89.1) | (75.2) | (54.6) | (17.3) |
| Income Before Tax | (35.0) | (58.2) | (76.4) | (88.2) | (75.8) | (55.2) | (17.3) |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income | (35.0) | (58.2) | (76.4) | (88.2) | (75.8) | (55.2) | (17.3) |
| Per Share Data | |||||||
| EPS (Basic) | -4.19 | -15.26 | -38.92 | -45.08 | -189.28 | -1475.88 | -592.06 |
| EPS (Diluted) | -4.19 | -15.26 | -38.92 | -45.08 | -189.28 | -1475.88 | -592.06 |
| Shares Outstanding | 83.6 | 3.8 | 2.0 | 2.0 | 0.4 | 0.0 | 0.0 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Current Assets | |||||||
| Cash & Cash Equivalents | 137.5 | 55.3 | 44.7 | 120.4 | 198.1 | 19.2 | 48.8 |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 5 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 2.5 | 4.9 | 3.4 | 4.1 | 4.5 | 0 | 1.0 |
| Total Current Assets | 145.0 | 60.2 | 48.1 | 124.5 | 202.5 | 20.6 | 51.1 |
| Non-Current Assets | |||||||
| Property, Plant & Equipment | 7.9 | 9.1 | 11.2 | 12.8 | 13.9 | 14.1 | 9.9 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 1.8 | 1.8 | 0 | 1.6 | 1.6 | 0 | 0.2 |
| Other Non-Current Assets | 0 | 0 | 1.6 | 0.3 | 0.1 | 1.7 | 1.6 |
| Total Non-Current Assets | 9.7 | 10.8 | 12.8 | 14.7 | 19.1 | 15.7 | 11.6 |
| Total Assets | 154.7 | 71.1 | 60.9 | 139.2 | 221.6 | 36.3 | 62.7 |
| Current Liabilities | |||||||
| Account Payables | 3.2 | 2.6 | 1.1 | 3.1 | 3.1 | 5.4 | 2.5 |
| Short-Term Debt | 1.3 | 0 | 3.3 | 6.7 | 0.9 | 2.3 | 0 |
| Deferred Revenue | 40.0 | 13.5 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 11.7 | 4.2 | 6.9 | 0.1 | 3.6 | 0 | 1.9 |
| Total Current Liabilities | 56.3 | 27.3 | 16.0 | 21.1 | 12.8 | 22.2 | 5.2 |
| Non-Current Liabilities | |||||||
| Long-Term Debt | 0 | 0 | 0 | 3.2 | 9.6 | 7.8 | 9.6 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 3.5 | 0 | 0 |
| Other Non-Current Liabilities | 57.5 | 0 | 0 | 0.0 | 0 | 0.5 | 0.4 |
| Total Non-Current Liabilities | 63.1 | 26.2 | 8.1 | 12.4 | 23.4 | 19.4 | 19.0 |
| Total Liabilities | 119.4 | 53.5 | 24.1 | 33.5 | 36.2 | 41.6 | 24.2 |
| Stockholders' Equity | |||||||
| Common Stock | 36.9 | 0.0 | 0.0 | 0.0 | 0.0 | 0 | 0 |
| Retained Earnings | (418.8) | (383.8) | (325.5) | (249.1) | (160.9) | (85.1) | (29.9) |
| Accumulated Other Comprehensive Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Stockholders' Equity | 35.3 | 17.6 | 36.8 | 105.6 | 185.4 | (5.3) | 38.5 |
| Total Liabilities & Equity | 154.7 | 71.1 | 60.9 | 139.2 | 221.6 | 36.3 | 62.7 |
| Debt Metrics | |||||||
| Total Debt | 7.0 | 8.1 | 11.5 | 19.9 | 20.7 | 21.9 | 18.6 |
| Net Debt | (130.6) | (47.1) | (33.2) | (100.4) | (177.3) | 2.6 | (30.2) |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||
| Net Income | (35.0) | (58.2) | (76.4) | (88.2) | (75.8) | (55.2) | (17.3) |
| Depreciation & Amortization | 1.5 | 1.6 | 1.9 | 1.8 | 1.5 | 1.1 | 0.2 |
| Stock-Based Compensation | 6.9 | 6.4 | 7.4 | 8.4 | 5.0 | 1.3 | 0.1 |
| Change in Working Capital | 25.1 | 31.8 | (1.7) | 2.0 | (11.8) | 16.6 | 0.8 |
| Other Non-Cash Items | (3.6) | 0.0 | 0.2 | 0.2 | 0.2 | 0.2 | 0.1 |
| Operating Cash Flow | (5.0) | (18.4) | (68.6) | (75.7) | (80.8) | (36.1) | (17.8) |
| Investing Activities | |||||||
| Capital Expenditure | (0.5) | (0.0) | (0.5) | (1.9) | (1.1) | (2.2) | (0.7) |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sales/Maturities of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | (0.5) | (0.0) | (0.5) | (1.9) | (1.1) | (2.2) | (0.7) |
| Financing Activities | |||||||
| Net Debt Issuance | 0 | (3.4) | (6.8) | (0.1) | (0.1) | (0.1) | 10.0 |
| Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | 25.8 | 0 | 0 | (0.5) | 0.2 | (10.0) |
| Financing Cash Flow | 87.8 | 29.2 | (6.5) | (0.1) | 260.7 | 10.0 | 60.0 |
| Cash Position | |||||||
| Net Change in Cash | 82.3 | 10.8 | (75.7) | (77.7) | 178.8 | (28.2) | 41.5 |
| Cash at Beginning | 57.1 | 46.3 | 120.4 | 198.1 | 20.8 | 49.0 | 7.6 |
| Cash at End | 139.3 | 57.1 | 44.7 | 120.4 | 199.6 | 20.8 | 49.0 |
| Free Cash Flow | (5.5) | (18.4) | (69.1) | (77.6) | (81.9) | (38.3) | (18.6) |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Income Statement | |||||||
| Revenue | 43.8 | 6.3 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 42.2 | 6.3 | 0 | 0 | (1.5) | (1.1) | (0.2) |
| Operating Income | (42.0) | (60.6) | (79.1) | (89.1) | (75.0) | (54.6) | (19.0) |
| Net Income | (35.0) | (58.2) | (76.4) | (88.2) | (75.8) | (55.2) | (17.3) |
| EPS (Diluted) | -4.19 | -15.26 | -38.92 | -45.08 | -189.28 | -1475.88 | -592.06 |
| Balance Sheet | |||||||
| Cash & Equivalents | 137.5 | 55.3 | 44.7 | 120.4 | 198.1 | 19.2 | 48.8 |
| Total Assets | 154.7 | 71.1 | 60.9 | 139.2 | 221.6 | 36.3 | 62.7 |
| Total Debt | 7.0 | 8.1 | 11.5 | 19.9 | 20.7 | 21.9 | 18.6 |
| Stockholders' Equity | 35.3 | 17.6 | 36.8 | 105.6 | 185.4 | (5.3) | 38.5 |
| Cash Flow | |||||||
| Operating Cash Flow | (5.0) | (18.4) | (68.6) | (75.7) | (80.8) | (36.1) | (17.8) |
| Capital Expenditure | (0.5) | (0.0) | (0.5) | (1.9) | (1.1) | (2.2) | (0.7) |
| Free Cash Flow | (5.5) | (18.4) | (69.1) | (77.6) | (81.9) | (38.3) | (18.6) |